Get started
Author

Evelyn Helena Ascendino da Mata

Observed names: Evelyn HA da Mata, Evelyn Helena Ascendino, Evelyn Mata, Évelyn H Ascendino
OpenAlex ID: A5111997714
First Report of the Hyper-IgM Syndrome Registry of the Latin American Society for Immunodeficiencies: Novel Mutations, Unique Infections, and Outcomes
2014 · Otavio Cabral-Marques, Stefanie Klaver, et al. · Journal of Clinical Immunology · 83
Identification of ANLN as ETV6 partner gene in recurrent t(7;12)(p15;p13): a possible role of deregulated ANLN expression in leukemogenesis
2015 · Paulo Vidal Campregher, Welbert de Oliveira Pereira, et al. · Molecular Cancer · 3
PDF
Genomic Profile of Patients with Triple Negative (JAK2, CALR and MPL) Essential Thrombocythemia and Primary Myelofibrosis
2014 · Paulo Vidal Campregher, Ricardo Helman, et al. · Blood · 2
Whole Exome Sequencing of Philadelphia-Negative (Ph-negative) Myeloproliferative Neoplasms (MPNs) and Myelodysplastic/Myeloproliferative Disorders (MDS/MPD)
2014 · Fabio P S Santos, Renato D Puga, et al. · Blood · 1
Incidence and Impact of Activating Mutations of the RAS-RAF-MEK-ERK Pathway in Patients with Philadelphia-Negative (Ph-negative) Myeloproliferative Neoplasms (MPNs) and Myelodysplastic/Myeloproliferative Disorders–Unclassified (MDS/MPD-U)
2014 · Fabio PS Santos, Bianca Lisboa, et al. · Blood · 1
Mutational Profiling of JAK2V617F vs. CALR mutated Primary Myelofibrosis
2015 · Fabio Santos, Renato Puga, et al. · Clinical Lymphoma Myeloma & Leukemia
The Presence of ASXL1 Mutations As Well As a Total Number of Myeloid Driver Mutations Higher Than Two Is Strongly Associated with the Diagnosis of Primary Myelofibrosis As Opposed to Essential Thrombocythemia
2014 · Paulo Vidal Campregher, Ricardo Helman, et al. · Blood
Works count: 7
Citation count: 90
H-index: 2
I10-index: 1
Year
Topic
Type